Thomas A. Steitz

Corporate Officer/Principal at Yale University

Health Technology

Consumer Services

Profile

Thomas A.
Steitz is the founder of Melinta Subsidiary Corp.
(founded in 2000) and Melinta Therapeutics, Inc. (founded in 2000).
He is currently a Professor at Yale University.

Thomas A. Steitz active positions

Companies	Position	Start
Yale University	Corporate Officer/Principal	-

All active positions of Thomas A. Steitz

Former positions of Thomas A. Steitz

Companies	Position	End
MELINTA THERAPEUTICS, INC.	Founder	-
Melinta Subsidiary Corp. Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT.	Founder	-

See the detail of Thomas A. Steitz's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Thomas A. Steitz's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Melinta Subsidiary Corp. Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT.	Health Technology
Melinta Therapeutics, Inc. Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ.	Health Technology